SIA "IVINA"Active

45403005195Limited liability companyFounded 1996

Key figures

1 077 206 €+9,8%
Revenue 2025
+20,4%
Average annual growth 2011–2025
0500 k1 m1,5 m’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Ratios

2025
Balance sheet structure
Current assetsNon-current assetsLiabilitiesEquity
0100 k200 k300 k’11’12’13’14’15’16’17’18’19’20’21’22’23’24’25

Dividends

calculated
2025

Paid out in dividends approximately 26 908 € (90% of equity at the end of the previous year).

Low confidence: the company does not file a cash flow statement, so the amount is an estimate from changes in equity — it may also include other reductions of equity (e.g. a share capital reduction).

History
2025 ~26 908 €
2024 ~29 829 €
2023 ~41 471 €
2022 ~28 631 €
2021 ~56 620 €
2020 ~47 963 €
2019 ~56 125 €
2018 ~53 199 €
20170 €
20160 €
20150 €
20140 €
20130 €
20120 €
Summary of financial statements2011–2025
201120122013201420152016201720182019202020212022202320242025
Balance sheet — assets
Total current assets12 66015 19514 61420 651108 214119 038206 276211 493187 886203 990186 360216 908202 832200 585212 174
Total non-current assets4700341524201197125135883045212422106974490156
Total assets12 70715 19514 61424 066110 634120 235206 401212 851188 716204 442187 602219 014203 806201 075212 330
Balance sheet — liabilities and equity
Current liabilities12 26214 853995436 905128 571110 945150 356153 880137 907144 976156 125174 697171 131171 321149 487
Non-current liabilities453243308519000000000000
Total liabilities16 79419 18318 47336 905128 571110 945150 356153 880137 907144 976156 125174 697171 131171 321149 487
Share capital———————————————
Retained earnings of previous periods———————————————
Profit for the year73899129-7349-10 46232 59146 75556 12547 96356 62028 63141 47129 82926 90859 997
Total equity-4087-3988-3859-12 839-23 301929056 04558 97150 80959 46631 47744 31732 67529 75462 843
Income statement
Sales revenue80 47585 68094 953138 150377 853539 926730 784728 000744 473754 193792 526842 513886 279980 8051 077 206
Operating profit1106242174-7349-10 46234 88156 17656 07661 96268 55542 98649 50441 27634 29166 761
Profit before income tax75799129-7349-10 46234 88156 17656 14262 03668 64143 07849 62541 55034 39366 761
Profit for the reporting year73899129-7349-10 46232 59146 75556 12547 96356 62028 63141 47129 82926 90859 997
Labour costs———————————————
Depreciation of non-current assets———————————————
Other indicators
Employees554456676666765
Calculated dividend—00000053 19956 12547 96356 62028 63141 47129 82926 908

A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.

Connections graph

Click a node to see its other connections.

100%SIA "IVINA"EUROAPTIEKA FARMĀCIJA…6Zaharova Nataļja2Drunka RonaldsDžeriņa ZaneMoskovkina Jūlija
CompanyPersonShareholderOther roleAdditional link

Related companies

Summary: SIA "IVINA"

Overview

SIA "IVINA" (reg. no. 45403005195) is a limited liability company. The company was registered in 1996 and has been in the register for 30 years. Registered address: Rīga, Cēsu iela 31 k-1.

Financial results

Revenue in 2025 was 1 077 206 €, up 9,8% on the previous year (980 805 €). From 2011 to 2025, revenue grew by an average of 20,4% per year. This is the company's highest revenue among the published years (2011–2025). Net profit for 2025 was 59 997 € (5,6% of revenue). The company was profitable in 13 of the 15 published years. In 2025 the company had 5 employees (6 a year earlier). Revenue per employee was 215 441 €. At the end of 2025, total assets were 212 330 € and equity 62 843 € (29,6% of assets).

Management and owners

The board has 4 members. The sole owner of the company is EUROAPTIEKA FARMĀCIJA, SIA.

Data sources and freshness

Register data (name, address, legal form, board and owners) and annual report figures come from the open data of the Register of Enterprises of the Republic of Latvia (CC0); entity.lv updates them daily. Data as of 03.11.2026. Changes, averages and ratios are calculated by entity.lv from open data and are not an official assessment.